ABVC BioPharma, Inc. (ABVC)
Nasdaq: ABVC · Pharmaceutical Preparations · Fremont, CA · filing with the SEC since 2002
Filings
401 filings since 2017 beside 13 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 62 days after the quarter ended. The proxy statement was last filed Sep 29, 2026.
Filings a yearinsider forms included
3923493663724728
2026 counts to Nov 13, 2026.
Auditor change (8-K item 4.01): 3 times in the last 36 months, the newest Jul 2, 2026.Warning not to rely on past financial statements (8-K item 4.02): 3 times in the last 36 months, the newest Mar 3, 2026.Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Oct 30, 2025.Listing warning from its exchange (8-K item 3.01): 5 times in the last 36 months, the newest May 14, 2025.SEC letters: 7 in the last 36 months, the newest Jun 27, 2024.A late-filing notice, Form NT 10-Q, filed May 15, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.A late-filing notice, Form NT 10-Q, filed May 15, 2024.A late-filing notice, Form NT 10-Q, filed Nov 14, 2023.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 2, 2026
8-K items 1.01, 1.02, 2.03, 3.02, 5.07, 7.01, 9.01
Major agreement signed; Major agreement ended; New debt or obligation taken on; Shares sold without registration; Shareholder vote; Investor disclosure (Regulation FD) · Current report
Oct 30, 2026
Aug 27, 2026
8-K items 1.01, 2.01, 7.01, 9.01
Major agreement signed; Purchase or sale of a business completed; Investor disclosure (Regulation FD) · Current report
Mar 3, 2026
8-K items 2.02, 4.02, 9.01
Results released; Warning not to rely on past financial statements · Current report
Jan 16, 2026
8-K/A items 3.02, 9.01
Shares sold without registration · Current report, amended
Apr 30, 2025
40 of 401 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.